CYCLACEL PHARMACEUTICALS INC's ticker is CYCC and the CUSIP is 23254L405. A total of 17 filers reported holding CYCLACEL PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $1,025,000 | -51.4% | 559,900 | 0.0% | 0.31% | -58.2% |
| Q2 2017 | $2,111,000 | +2.5% | 559,900 | 0.0% | 0.75% | +0.5% |
| Q1 2017 | $2,060,000 | +8.2% | 559,900 | +55.6% | 0.74% | -26.6% |
| Q4 2016 | $1,904,000 | -11.8% | 359,900 | 0.0% | 1.02% | +13.4% |
| Q3 2016 | $2,159,000 | – | 359,900 | – | 0.90% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 559,900 | $2,111,000 | 0.75% |
| WEDBUSH SECURITIES INC | 13,900 | $52,000 | 0.01% |
| MinichMacGregor Wealth Management, LLC | 800 | $3,000 | 0.00% |
| UBS Group AG | 180 | $1,000 | 0.00% |
| D'Orazio & Associates, Inc. | 100 | $0 | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 30,913 | $117,000 | 0.00% |
| Parallel Advisors, LLC | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 21,692 | $82,000 | 0.00% |
| DEUTSCHE BANK AG\ | 2,403 | $9,000 | 0.00% |
| PANAGORA ASSET MANAGEMENT INC | 10,346 | $39,000 | 0.00% |